ArticleThe Journal of infectious diseases2010

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients.

Elias K Halvas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.